Ashkan Adibi

机构：Turkish Society of Hematology, Precision for Medicine (United States) · ORCID：0000-0002-0505-1558

发表论文 20 篇 · 总被引 64 次 · h-index 5

代表论文

• Role of CT and MRI prior to redo sternotomy in paediatric patients with congenital heart disease (2014 · Clinical Radiology · 被引 13)
• PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview (2023 · Therapeutic Advances in Medical Oncology · 被引 9)
• Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview (2023 · JCO Precision Oncology · 被引 8)
• Therapeutic vulnerabilities and pan-cancer landscape of BRAF class III mutations in epithelial solid tumors (2024 · BJC Reports · 被引 7)
• Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers (2024 · Current Oncology · 被引 5)
• Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety (2024 · Therapeutic Advances in Medical Oncology · 被引 5)